ATLASATLAS fair value
CHF 403.60
Close to fair value · 4% discount
Range: CHF 301–CHF 536Fair valuePrice
Ypsomed (YPSN.SW)
Ypsomed stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · SIX Swiss Exchange · Switzerland
CHF 387.40▲ +0.41%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Ypsomed in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Ypsomed
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Ypsomed's fair value at about CHF 403.60 per share (reasonable range: CHF 301.13 to CHF 535.53). At CHF 387.40, the stock trades within 8% of that figure: close to fair value.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Ypsomed a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 370.18 and CHF 407.52; in 9 out of 10, between CHF 339.96 and CHF 443.76. Estimated annual volatility is 26%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 5.0B
- Market cap (USD)
- $6.0B
- P/E ratio
- 23.4
- Dividend yield
- 1.16%
- 52-week high
- CHF 418.00
- 52-week low
- CHF 260.50
- Revenue (12 months)
- CHF 731M
- Gross margin
- 43.0%
- Operating margin
- 26.5%
- Net margin
- 30.4%
- Beta
- 0.81
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Ypsomed sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks YPSN.SW has traded between CHF 260.50 and CHF 418.00. Today it is 7.3% below that high and 49% above its low.
On the business: net margin is 30.4%; it trades at 23.4 times earnings.
Its beta is 0.81: it tends to move less than the market.
About the company
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Want to see everything about Ypsomed?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Ypsomed (YPSN.SW) fair value?
About CHF 403.60 per share according to ATLAS (reasonable range: CHF 301.13 to CHF 535.53). With the stock at CHF 387.40, it is close to that value.
What is the chance YPSN.SW goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, YPSN.SW ends the month between CHF 370.18 and CHF 407.52.
How big is Ypsomed and what is its P/E ratio?
Ypsomed's market capitalization is CHF 5.0B. Its price-to-earnings (P/E) ratio is 23.4: you pay CHF 23.4 for each CHF 1.00 of yearly earnings.
Does Ypsomed pay a dividend?
Yes. YPSN.SW's current dividend yield is 1.16% at today's price (CHF 387.40).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer